Bioorganic & Medicinal Chemistry Letters 2012-02-15

Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors.

Bo Song, Tong Xiao, Xiaolu Qi, Ling-Na Li, Kuiyou Qin, Siyun Nian, Guo-Xin Hu, Yinfei Yu, Guang Liang, Faqing Ye

Index: Bioorg. Med. Chem. Lett. 22(4) , 1739-42, (2012)

Full Text: HTML

Abstract

Monoamine oxidase-B (MAO-B) inhibitor has been used as neuroprotectants to treat the motor deficits of Parkinson's disease (PD). We designed and synthesized a class of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. The compounds have various inhibitory effects, with compound 6a having a K(i) value of 0.26 μM. Their promising activity in vitro suggests potential use in the treatment of PD.Copyright © 2012 Elsevier Ltd. All rights reserved.

Related Compounds

  • Istradefylline

Related Articles:

On the role of adenosine (A)₂A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats.

2015-01-01

[Psychopharmacol. Ser. 232(2) , 421-35, (2015)]

Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.

2013-09-01

[Neuropharmacology 72 , 197-203, (2013)]

Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.

2009-09-29

[Neuroscience 163(1) , 97-108, (2009)]

Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on Δ9-tetrahydrocannabinol (THC) self-administration in squirrel monkeys.

2014-05-07

[J. Neurosci. 34(19) , 6480-4, (2014)]

Population pharmacokinetic analysis of istradefylline in healthy subjects and in patients with Parkinson's disease.

2011-01-01

[J. Clin. Pharmacol. 51(1) , 40-52, (2011)]

More Articles...